Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
NCT ID: NCT00001376
Last Updated: 2008-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
209 participants
OBSERVATIONAL
1994-08-31
2000-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We expect to find that pregnancy is associated with enhanced Th2 cytokine expression and that the postpartum state is associated with enhanced Th1 cytokine expression. We expect to see differences in cytokine expression between males and females as well. We seek to gather data supporting the view that distinct hormonal environments regulate these contrasting immunological states.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
NCT00116272
Cytokines Profile at the Beginning of Pregnancy
NCT03761966
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214
Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development
NCT01623934
Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum
NCT05504889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We expect to find that pregnancy is associated with enhanced Th2 cytokine expression and that the postpartum state is associated with enhanced Th1 cytokine expression. We expect to see differences in cytokine expression between males and females as well. We seek to gather data supporting the view that distinct hormonal environments regulate these contrasting immunological states.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bell SC, Billington WD. Major anti-paternal alloantibody induced by murine pregnancy is non-complement-fixing IgG1. Nature. 1980 Nov 27;288(5789):387-8. doi: 10.1038/288387a0.
Cadet P, Rady PL, Tyring SK, Yandell RB, Hughes TK. Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol. 1995 Jul;173(1):25-9. doi: 10.1016/0002-9378(95)90164-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
94-AR-0196
Identifier Type: -
Identifier Source: secondary_id
940196
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.